Read the full feature about the shady business and questionable science behind hypoallergenic cats.
Please download the Adobe Flash Player to view this content:
Slideshow: Reporter's log on Allerca Read the full feature about the shady business and questionable science behind hypoallergenic cats. var FO = { movie:"http://www.the-scientist.com/supplementary/flash/39695/allerca_slideshow.swf", width:"600", height:"600", majorversion:"8", build:"0", xi:"true"}; UFO.create(FO, "ufoDemo"); Please download the Adobe Flash Player to view this content:
Read the full feature about the shady business and questionable science behind hypoallergenic cats.
Please download the Adobe Flash Player to view this content:
Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.
A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.
View this IssueIn this webinar, Ethan Shelkey and Aurita Menezes will highlight key aspects in the design of cell-based assays.
Discover how alternative animal models provide new perspectives on physiological and biochemical processes.
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
Multiomics platform streamlines workflows and provides real-time insights, optimizing resource usage and ensuring smooth, data-driven operations
Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology designed to accelerate drug discovery and disease research with unprecedented scalability, reproducibility, and efficiency.
Learn how a target enrichment approach improves the discovery and characterization of viral pathogens.
Zymo Research is proud to introduce the Master the Microbiome Grant, a global initiative dedicated to advancing research in microbiomics, metagenomics, and microbial sciences.